Lineage Cell Therapeutics (LCTX) Assets (2010 - 2026)
Lineage Cell Therapeutics' Assets came in at $106.22 million for Q2 2026, up 17.0% from $90.8 million a year earlier but down 3.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Lineage Cell Therapeutics' Assets was $112.58 million, down 0.6% from FY2024.
- Assets carries a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Going back by year, Assets was $113.22 million in FY2024 (+12.1%), $101.02 million in FY2023 (-18.3%), $123.66 million in FY2022 (-29.2%) and $174.55 million in FY2021 (+61.7%).
- The five-year range for quarterly Assets is $89.64 million (Q3 2025) to $174.55 million (Q4 2021).
- Year-over-year, Assets increased in three of the last eight quarters, with growth averaging 0.2%.
- The fastest year-over-year change in Assets over five years came in Q4 2021 (growth of 61.7%), and the weakest in Q4 2022 (a decline of 29.2%).
- Business Quant data shows LCTX's Assets at $109.53 million (Q1 2026), $112.58 million (Q4 2025) and $89.64 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 106.22 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106.22 Mn |
| Mar 31, 2026 | 109.53 Mn |
| Dec 31, 2025 | 112.58 Mn |
| Sep 30, 2025 | 89.64 Mn |
| Jun 30, 2025 | 90.80 Mn |
| Mar 31, 2025 | 111.75 Mn |
| Dec 31, 2024 | 113.22 Mn |
| Sep 30, 2024 | 96.59 Mn |
| Jun 30, 2024 | 102.80 Mn |
| Mar 31, 2024 | 108.48 Mn |
| Dec 31, 2023 | 101.02 Mn |
| Sep 30, 2023 | 106.15 Mn |
| Jun 30, 2023 | 111.69 Mn |
| Mar 31, 2023 | 113.21 Mn |
| Dec 31, 2022 | 123.66 Mn |
| Sep 30, 2022 | 131.15 Mn |
| Jun 30, 2022 | 135.92 Mn |
| Mar 31, 2022 | 144.52 Mn |
| Dec 31, 2021 | 174.55 Mn |
| Sep 30, 2021 | 131.21 Mn |
API Access
Lineage Cell Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();